Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Site News
Market: Market:

Cardiol Therapeutics (CRTPF)

Cardiol Therapeutics (CRTPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Cardiol Therapeutics' Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman Newsfile Corp - Wed Jul 7, 6:35AM CDT

Oakville, Ontario--(Newsfile Corp. - July 7, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting Newsfile Corp - Wed Jun 30, 9:06AM CDT

Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT Newsfile Corp - Mon Jun 28, 9:06AM CDT

Oakville, Ontario--(Newsfile Corp. - June 28, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development PR Newswire - PRF - Tue Jun 15, 8:15AM CDT

/PRNewswire/ -- The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get...

OILFF : 0.1849 (+3.41%)
OILS.CN : 0.230 (+4.55%)
MNMD : 3.06 (+0.99%)
LKYSF : 0.7778 (+4.08%)
NUMI.VN : 0.970 (+4.30%)
FTRPF : 5.7460 (-2.32%)
FTRP.CN : 5.550 (+1.46%)
CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Newsfile Corp - Wed Apr 28, 5:08AM CDT

Oakville, Ontario--(Newsfile Corp. - April 28, 2021) - ()()()(or the), a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM) Newsfile Corp - Mon Apr 12, 6:41AM CDT

Oakville, Ontario--(Newsfile Corp. - April 12, 2021) - ()()()(or the), a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A Newsfile Corp - Thu Apr 1, 7:45AM CDT

Oakville, Ontario--(Newsfile Corp. - April 1, 2021) - () ()()(""or the ""),a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer Newsfile Corp - Tue Mar 30, 6:05AM CDT

Oakville, Ontario--(Newsfile Corp. - March 30, 2021) - () ()()(""or the ""),a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

AMGN : 241.54 (-0.38%)
CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options Newsfile Corp - Tue Mar 2, 6:29AM CST

Oakville, Ontario--(Newsfile Corp. - March 2, 2021) - () () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Newsfile Corp - Thu Jan 21, 6:28AM CST

Oakville, Ontario--(Newsfile Corp. - January 21, 2021) - () () ("" or the ""), a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics to Participate in Upcoming Virtual Investor Conferences Newsfile Corp - Thu Jan 7, 6:28AM CST

Oakville, Ontario--(Newsfile Corp. - January 7, 2021) - () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, announced...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx(TM) Newsfile Corp - Tue Dec 22, 2020

Oakville, Ontario--(Newsfile Corp. - December 22, 2020) - () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Newsfile Corp - Tue Dec 15, 2020

() () ("" or the ""), a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease ("CVD"), announces...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics' Cortalex(TM) CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc. Newsfile Corp - Tue Oct 20, 2020

() () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased to announce the commercial introduction of Cortalex, a...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
FDA Approves Landmark COVID/Heart/CBD Clinical Trial -- SECFilings.com Newsfile Corp - Wed Sep 30, 2020

Redondo Beach, California--(Newsfile Corp. - September 30, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial Newsfile Corp - Fri Sep 25, 2020

Oakville, Ontario--(Newsfile Corp. - September 25, 2020) - () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cannabidiol Phase 1 Clinical Trial Launches, Targeting Inflammatory Heart Condition -- SECFilings.com Newsfile Corp - Wed Sep 16, 2020

Redondo Beach, California--(Newsfile Corp. - September 16, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference Newsfile Corp - Tue Sep 15, 2020

Oakville, Ontario--(Newsfile Corp. - September 15, 2020) - () () ("" or the ""), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM) Newsfile Corp - Wed Aug 26, 2020

Oakville, Ontario--(Newsfile Corp. - August 26, 2020) - () () ("" or the ""), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Global Pandemic Creating Opportunities for Drug Companies to Earn Positive Market Attention PR Newswire - PRF - Thu Aug 6, 2020

, /PRNewswire/ -- In the last 18 years, viral disease epidemics have across the globe. Today's pandemic is quickly adding to the number of deaths while seriously disrupting economies, businesses, and...

GILD : 68.29 (-2.21%)
AZN : 57.24 (-0.69%)
PFE : 42.81 (+0.05%)
LLY : 243.50 (-0.75%)
CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Please wait...

Barchart Exclusives

When Weather and Weather Derivatives Diverge Barchart - Fri Jul 30, 11:11AM CDT
A look at the softs complex Friday morning shows us markets aren't looking at weather in Brazil to close out the month. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
Reserve Your Spot